Bank of Korea Raises Rates to 3% as Inflation Stays Sticky 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Asian Currencies Mixed as Dollar Holds Firm Ahead of Jackson Hole 
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Wall Street Slips as Warsh’s Hawkish Fed Speech Rattles Markets 
Oil Prices Slip as Venezuela Supply Prospects Weigh on Market 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Add as a preferred source on Google
Keio University researchers have successfully transplanted into a patient with a severe spinal cord injury two million neural progenitor cells derived from other people’s iPS cells as part of a clinical study, offering hope for the paralyzed.
The patient is doing well.
Over the next year, while the patient undergoes rehabilitation, the team of doctors will see how safe and effective the treatment is.
The treatment is designed for patients with “complete paralysis” who are within two to four weeks of sustaining a spinal cord injury, called the subacute phase.
The iPS cells used were stockpiled by Kyoto University’s Center for iPS Cell Research and Application.
While rehabilitation is currently the only effective treatment for a spinal cord injury, the team believes that the transplanted cells could repair damaged neural circuits and create new tissue that can transmit signals from the brain.
The team plans to do the transplant into four more patients with spinal cord injuries.
While Japan’s Ministry of Health, Labor, and Welfare approved this clinical trial in February 2019, the process of finding suitable patients was postponed due to the COVID-19 pandemic.
